Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity(legacy) | 109 |
| Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity(legacy) | 73 |
Total Visits per Month
| March 2023 | April 2023 | May 2023 | June 2023 | July 2023 | August 2023 | September 2023 | |
|---|---|---|---|---|---|---|---|
| Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity | 2 | 0 | 3 | 0 | 0 | 2 | 5 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 74 |
| Germany | 18 |
| China | 10 |
| France | 10 |
| Australia | 9 |
| Netherlands | 8 |
| Vietnam | 6 |
| Ireland | 2 |
| Brazil | 1 |
| Canada | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 22 |
| Fairfield | 9 |
| Rotterdam | 8 |
| Buffalo | 6 |
| Hanoi | 6 |
| Kaleen | 6 |
| Des Moines | 5 |
| San Ramon | 3 |
| Zhengzhou | 3 |
| Beijing | 2 |